As in previous studies, IOCS in patients with placenta accreta was found to reduce the need for ABT.[7] ABT was avoided in 70 (98.6%) of the 71 women with a blood loss volume ≤3000 mL and a preoperative Hb level>100 g/L. This evidence concerns the gene GSTM1 and placenta accreta.